We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 7,950 results
  1. Integrative blood-based characterization of oxidative mitochondrial DNA damage variants implicates Mexican American’s metabolic risk for develo** Alzheimer’s disease

    Alzheimer’s Disease (AD) continues to be a leading cause of death in the US. As the US aging population (ages 65 +) expands, the impact will...

    Danielle Marie Reid, Robert C. Barber, ... Nicole R. Phillips in Scientific Reports
    Article Open access 07 September 2023
  2. Intelligent prediction of Alzheimer’s disease via improved multifeature squeeze-and-excitation-dilated residual network

    This study aimed to address the issue of larger prediction errors existing in intelligent predictive tasks related to Alzheimer’s disease (AD). A...

    Zengbei Yuan, **nlin Li, ... Tao Wu in Scientific Reports
    Article Open access 25 May 2024
  3. Non-invasive modulation of meningeal lymphatics ameliorates ageing and Alzheimer’s disease-associated pathology and cognition in mice

    Meningeal lymphatic vessels (mLVs) have been shown to be involved in amyloid beta (Aβ) clearance, which is considered as a potential therapeutic...

    Miao Wang, Congcong Yan, ... Feifan Zhou in Nature Communications
    Article Open access 16 February 2024
  4. Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease

    Which isoforms of apolipoprotein E (apoE) we inherit determine our risk of develo** late-onset Alzheimer’s Disease (AD), but the mechanism...

    Zengjie **a, Emily E. Prescott, ... Suman De in Nature Communications
    Article Open access 01 June 2024
  5. Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease

    Mechanisms through which most known Alzheimer’s disease (AD) loci operate to increase AD risk remain unclear. Although Apolipoprotein E (APOE) is...

    Hannah Compton, Madeleine L. Smith, ... Emma L. Anderson in Scientific Reports
    Article Open access 16 February 2024
  6. Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer’s disease

    We aimed to study atrophy and glucose metabolism of the cholinergic basal forebrain in non-demented mutation carriers for autosomal dominant...

    Stefan Teipel, Alice Grazia, ... Nunzio Pomara in Scientific Reports
    Article Open access 17 May 2024
  7. JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer’s disease

    Adult neurogenic decline, inflammation, and neurodegeneration are phenotypic hallmarks of Alzheimer’s disease (AD). Mobilization of transposable...

    Chiara Scopa, Samantha M. Barnada, ... Marco Trizzino in Nature Communications
    Article Open access 04 December 2023
  8. Blood pressure variability and plasma Alzheimer’s disease biomarkers in older adults

    Blood pressure variability is an emerging risk factor for Alzheimer’s disease in older adults, independent of average blood pressure levels. Growing...

    Isabel J. Sible, Belinda Yew, ... Daniel A. Nation in Scientific Reports
    Article Open access 13 October 2022
  9. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer’s disease

    Alzheimer’s disease (AD) predominantly occurs as a late onset (LOAD) form involving neurodegeneration and cognitive decline with progressive memory...

    Victor Lau, Leanne Ramer, Marie-Ève Tremblay in Nature Communications
    Article Open access 25 March 2023
  10. A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer’s disease

    Brain perfusion and blood-brain barrier (BBB) integrity are reduced early in Alzheimer’s disease (AD). We performed single nucleus RNA sequencing of...

    Stergios Tsartsalis, Hannah Sleven, ... Paul M. Matthews in Nature Communications
    Article Open access 12 March 2024
  11. Properties of odor identification testing in screening for early-stage Alzheimer’s disease

    Odor identification (OI) is impaired in the early stages of Alzheimer’s disease (AD). However, data regarding the diagnostic properties of OI tests...

    Egle Audronyte, Gyte Pakulaite-Kazliene, ... Gintaras Kaubrys in Scientific Reports
    Article Open access 13 April 2023
  12. Resting-state oscillations reveal disturbed excitation–inhibition ratio in Alzheimer’s disease patients

    An early disruption of neuronal excitation–inhibition (E–I) balance in preclinical animal models of Alzheimer’s disease (AD) has been frequently...

    Anne M. van Nifterick, Danique Mulder, ... Alida A. Gouw in Scientific Reports
    Article Open access 07 May 2023
  13. Effect of exercise on the hypothalamic–pituitary–gonadal axis in a rat model of Alzheimer’s disease

    Hypothalamic–pituitary–gonadal (HPG) axis dysregulation was suggested to play a crucial role in Alzheimer’s disease (AD). This study investigated the...

    Eman Y. khairy, Ola A. Salama in Scientific Reports
    Article Open access 31 August 2023
  14. Performance of SOBA-AD blood test in discriminating Alzheimer’s disease patients from cognitively unimpaired controls in two independent cohorts

    Amyloid-beta (Aβ) toxic oligomers are critical early players in the molecular pathology of Alzheimer’s disease (AD). We have developed a Soluble...

    Amy Chen, Dylan Shea, Valerie Daggett in Scientific Reports
    Article Open access 04 April 2024
  15. Downregulation of miR-181c-5p in Alzheimer’s disease weakens the response of microglia to Aβ phagocytosis

    Alzheimer’s disease (AD) is an age-associated neurodegenerative disease. Recently, studies have demonstrated the potential involvement of...

    Rongjie Li, Shanshan Yao, ... Ying Liu in Scientific Reports
    Article Open access 20 May 2024
  16. Altered cerebrovascular-CSF coupling in Alzheimer’s Disease measured by functional near-infrared spectroscopy

    In-vivo microscopical studies indicate that brain cerebrospinal fluid (CSF) transport driven by blood vessel pulsations is reduced in the early...

    Hany Ferdinando, Sadegh Moradi, ... Teemu Myllylä in Scientific Reports
    Article Open access 15 December 2023
  17. Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation

    Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) plaques followed by intracellular...

    Daniel C. Shippy, Tyler K. Ulland in Scientific Reports
    Article Open access 08 September 2023
  18. Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease

    Autosomal dominant Alzheimer’s disease (ADAD) is genetically determined, but variability in age of symptom onset suggests additional factors may...

    Stephanie Langella, N. Gil Barksdale, ... Yakeel T. Quiroz in Nature Communications
    Article Open access 23 August 2023
  19. Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease

    We evaluated the patterns of quantitative electroencephalography (EEG) in patients with Alzheimer’s disease (AD), Lewy body disease (LBD), and mixed...

    Kyoungwon Baik, ** Ho Jung, ... Byoung Seok Ye in Scientific Reports
    Article Open access 04 November 2022
  20. Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic model

    Alzheimer’s disease (AD) is the most prevalent dementia disorder globally, and there are still no effective interventions for slowing or stop** the...

    Yanting Zhang, Hisanori Kiryu in Scientific Reports
    Article Open access 26 April 2023
Did you find what you were looking for? Share feedback.